Pages that link to "Q36487119"
Jump to navigation
Jump to search
The following pages link to Current and emerging pharmacological treatment options for dementia (Q36487119):
Displaying 25 items.
- M1 receptors mediate cholinergic modulation of excitability in neocortical pyramidal neurons. (Q24653082) (← links)
- Targeting amyloid-beta in glaucoma treatment. (Q24681763) (← links)
- Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview (Q26750581) (← links)
- Non Pharmacological Cognitive Enhancers - Current Perspectives (Q26782439) (← links)
- Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease (Q28287090) (← links)
- Zebrafish: An in vivo model for the study of neurological diseases (Q30493208) (← links)
- Meeting the unique challenges of drug discovery for neurodegenerative diseases (Q33469818) (← links)
- Therapy for Alzheimer's Disease: How Effective are Current Treatments? (Q34409349) (← links)
- The impact of Medicare prescription drug coverage on the use of antidementia drugs (Q34690333) (← links)
- Risk and predictability of drug interactions in the elderly (Q36791600) (← links)
- Donepezil treatment in ethnically diverse patients with Alzheimer disease (Q36920714) (← links)
- Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme (Q37130148) (← links)
- Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer's disease (Q37961834) (← links)
- Effect of selective serotonin reuptake inhibitors in Alzheimer's disease with comorbid depression: a meta-analysis of depression and cognitive outcomes (Q38053311) (← links)
- M1 muscarinic acetylcholine receptor in Alzheimer's disease (Q38192962) (← links)
- Molecular Pathogenesis of Alzheimer's Disease: An Update (Q39355183) (← links)
- Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease (Q42646408) (← links)
- Concurrent use of anticholinergic drugs and cholinesterase inhibitors: register-based study of over 700,000 elderly patients (Q46353578) (← links)
- Effects of memantine and MK-801 on ischemia in an experimental model of acute subdural hematoma (Q46778010) (← links)
- Cognitive intervention for early stage dementia: Research and techniques (Q47961167) (← links)
- Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET. (Q48268462) (← links)
- Dementia in life writing: our health care system in the words of the sufferer (Q48450927) (← links)
- FRONTIER Executive Screen: a brief executive battery to differentiate frontotemporal dementia and Alzheimer's disease. (Q50705223) (← links)
- Strengthening the Brain-Is Resistance Training with Blood Flow Restriction an Effective Strategy for Cognitive Improvement? (Q57289957) (← links)
- Spouse and adult child differences in caregiving burden (Q85361523) (← links)